Noncommunicable Diseases in Saudi Arabia

Page 193

Screening to Promote Early Detection | 171

TABLE 8.1  Screening

uptake for breast and colorectal cancer in Saudi Arabia and the United States

uptake (% of population) TYPE OF SCREENING

SAUDI ARABIA

UNITED STATES

REFERENCES

Colorectal cancer screening

15% of the population ages 18–78% have ever been screened for colorectal cancer

63% of the population ages 50–75 have had one of the following:

Almadi and Alghamdi 2019; Hall et al. 2018

(1) A fecal occult blood test in the past year (2) A flexible sigmoidoscopy in the past five years plus a fecal occult blood test within the past three years (3) A colonoscopy within the past 10 years

Breast cancer screening

8% of women ages 50–74 have ever had a mammogram (2013) 9.9% of ever-married women ages 30–69 have ever had a mammogram (2019)

72% of women ages 50–64 years have had a mammogram within the last two years

Source: Original compilation for this publication.

persons 15 years of age and older had high blood pressure, with 58 percent undiagnosed (El Bcheraoui et al. 2014a); 13 percent had high blood sugar, with 58 ­percent undiagnosed (El Bcheraoui et al. 2014b); and 9 percent had hypercholesterolemia, with 65 percent undiagnosed (Basulaiman et al. 2014). The rate of undiagnosed type 2 diabetes is similar in Saudi Arabia and the United States, whereas the rates of undiagnosed hypertension and lipid disorders are somewhat higher in Saudi Arabia than in the United States (table 8.2). The 2019 Kingdom of Saudi Arabia World Health Survey confirms that the rates of ­undiagnosed hypertension, diabetes, and hypercholesterolemia remain high (MOH 2020).

Supply-side determinants of screening uptake Generally, screening in Saudi Arabia is not conducted in a systematic manner. Clinical guidelines exist for some types of screening (for example, Al-Mandeel et al. 2016), but government agencies and facilities have done little to promote screening. The most prominent efforts to increase the uptake of mammography have been spearheaded by nonprofit groups, not government agencies or health care providers (Abulkhair et al. 2010; Al Mulhim et al. 2015). Basic information about how and where to get screened for cancer is limited. According to Gosadi (2019, 613), researchers in Saudi Arabia “found difficulties finding information related to the availability of screening tests for breast cancer and colon cancer, and this may explain the low utilization of screening services.” It is unclear to what extent cancer screening is available throughout the country. According to El Bcheraoui et al. (2015a, 5), mammography has been available in all regions of the country since 2005. However, English-language internet searches using multiple search terms and multiple search engines found little information about mammography in Saudi Arabia. One survey finds that most physicians do not prescribe colorectal cancer screening. A survey at a Riyadh clinic finds that physicians are knowledgeable

El Bcheraoui et al. 2015a; Hall et al. 2018; MOH 2020


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

9.2 Focus on three levels of prevention in the master plan

2min
page 226

sector

1min
page 228

Methodological approach Identification of stakeholders influencing and participating in

4min
pages 236-237

in Saudi Arabia

2min
page 241

diets in Saudi Arabia

2min
page 240

9.5 Benefits of targeting settings

1min
page 231

Prioritizing prevention over treatment

2min
page 225

References

30min
pages 208-218

plans

1min
page 223

Cost-effectiveness of screening

2min
page 198

Effectiveness of interventions to increase screening uptake

2min
page 201

8.6 Cost-effectiveness of screening

4min
pages 202-203

Diseases

1min
page 222

Cost-effectiveness of screening promotion interventions Information gaps, policy recommendations, and future research

2min
page 204

8.3 Recommendations regarding screening in comparative countries

4min
pages 196-197

Effectiveness of screening

2min
page 195

United States

2min
page 193

Screening in Saudi Arabia

2min
page 192

7.17 Evidence on cost-effectiveness of diet-related interventions

5min
pages 166-167

7.16 Evidence on cost-effectiveness of tobacco control interventions

3min
page 165

Cost-effectiveness of population-wide interventions

1min
page 164

7.13 Evidence on effectiveness of setting nutrition standards

2min
page 159

7.10 Evidence on effectiveness of BOP and FOP labeling

3min
page 157

e-cigarettes

2min
page 155

7.6 Evidence of effectiveness of e-cigarette tax

2min
page 154

Saudi Arabia

2min
page 152

Conclusions

1min
page 131

Saudi Arabia

2min
page 150

Saudi Arabia

2min
page 151

Noncommunicable Diseases

5min
pages 143-144

Plan

1min
page 128

Methodology

2min
page 124

References

17min
pages 116-122

Annex 5B: Methodology for estimating the impact of NCDs on HCI

2min
page 115

Annex 5A: Approaches to estimating the economic burden of NCDs

2min
page 114

North Africa

5min
pages 104-105

5.4 NCDs and human capital: Transmission mechanisms

15min
pages 107-112

Conclusions

2min
page 113

Summary and conclusions Annex 4A: Methodology for estimating the economic impact

2min
page 96

Economic burden using the value of a statistical life method Economic burden using the economic growth approach

5min
pages 93-94

References

4min
pages 61-62

3A.2 Adjusted decrease in salt intake and changes to systolic blood pressure in Saudi Arabia, by gender 3A.3 Prevalence estimates for overweight and obesity in Saudi Arabia, by age and

2min
page 78

Economic burden using the cost-of-illness method

2min
page 89

3 Disease prevalence in the employed working-age population in

3min
page 26

3.1 Years of life lost, years lost due to disability, and healthy life expectancy

3min
page 64

and 2019

1min
page 39

3.2 Definition of risk factors for at-risk populations

5min
pages 67-68

Conclusions

2min
page 76
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Noncommunicable Diseases in Saudi Arabia by World Bank Publications - Issuu